Liarozole (R75251; R85246)是一种咪唑衍生物,作为口服有效的维甲酸 (RA) 代谢阻断剂 (RAMBA),它抑制维甲酸依赖的细胞色素P450 (CYP26) 4-羟基化,IC50为7 μM,从而增加组织维甲酸水平,并具有抗肿瘤特性。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Liarozole is an imidazole derivative and metabolic blocker of retinoic acid with oral activity. Liarozole inhibits CYP26-dependent 4-hydroxylation of retinoic acid with an IC50 value of 7 μM, leading to an increase in tissue levels of retinoic acid. Liarozole possesses antitumour properties[1][2][3].In MCF-7 cells, Liarozole inhibits cell proliferation at concentrations ranging from 0.01-10 μM for 9 days of treatment[3].In mesenchymal cells, Liarozole completely inhibited chondrogenesis at a concentration of 1 μM for 4 days of treatment[4]. |
Animal study | At a dose of 5-20 mg/kg administered orally for 3 days, Liarozole reversed vaginal keratosis induced by estrogen stimulation[5].At a dose of 40 mg/kg administered orally for 21 days, Liarozole substantially reduced tumourr burden[6]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.24mL 0.65mL 0.32mL |
16.19mL 3.24mL 1.62mL |
32.39mL 6.48mL 3.24mL |
CAS号 | 115575-11-6 |
分子式 | C17H13ClN4 |
分子量 | 308.765 |
别名 | R75251 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,Room Temperature |
溶解度 |
DMSO: 105 mg/mL(340.06 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |